Bundamedik Tbk (Indonesia) Today
| BMHS Stock | 268.00 2.00 0.74% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Bundamedik Tbk is selling for 268.00 as of the 1st of December 2024. This is a 0.74 percent down since the beginning of the trading day. The stock's last reported lowest price was 262.0. Bundamedik Tbk has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Bundamedik Tbk PT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of June 2023 and ending today, the 1st of December 2024. Click here to learn more.
Moving together with Bundamedik Stock
Moving against Bundamedik Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bundamedik Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bundamedik Tbk's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bundamedik Tbk or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
Bundamedik Tbk PT (BMHS) is traded on Jakarta Exchange in Indonesia and employs 1,160 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.61 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bundamedik Tbk's market, we take the total number of its shares issued and multiply it by Bundamedik Tbk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bundamedik Tbk PT operates under Healthcare sector and is part of Medical Care Facilities industry. The entity has 8.6 B outstanding shares.
Bundamedik Tbk generates positive cash flow from operations, but has no cash available
Check Bundamedik Tbk Probability Of Bankruptcy
Ownership AllocationBundamedik Tbk holds a total of 8.6 Billion outstanding shares. Bundamedik Tbk PT shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.8 percent of Bundamedik Tbk PT outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bundamedik Ownership Details
Bundamedik Tbk PT Risk Profiles
Although Bundamedik Tbk's alpha and beta are two of the key measurements used to evaluate Bundamedik Tbk's performance over the market, the standard measures of volatility play an important role as well.
Bundamedik Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bundamedik Tbk without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Bundamedik Tbk Corporate Management
Elected by the shareholders, the Bundamedik Tbk's board of directors comprises two types of representatives: Bundamedik Tbk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bundamedik. The board's role is to monitor Bundamedik Tbk's management team and ensure that shareholders' interests are well served. Bundamedik Tbk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bundamedik Tbk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tedy MBA | Director Director | Profile | |
| Abdul Latif | Head Unit | Profile | |
| Mesha Sini | Pres Director | Profile | |
| Josephine Tobing | Co Sec | Profile | |
| Emilia Simatupang | Director Director | Profile |
Other Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.